Acute Respiratory Distress Syndrome and the Use of Inhaled Pulmonary Vasodilators in the COVID-19 Era: A Narrative Review
Open Access
Abstract
The Coronavirus disease (COVID-19) pandemic of 2019 has resulted in significant morbidity and mortality, especially from severe acute respiratory distress syndrome (ARDS). As of September 2022, more than 6.5 million patients have died globally, and up to 5% required intensive care unit treatment. COVID-19-associated ARDS (CARDS) differs from the typical ARDS due to distinct pathology involving the pulmonary vasculature endothelium, resulting in diffuse thrombi in the pulmonary circulation and impaired gas exchange. The National Institute of Health and the Society of Critical Care Medicine recommend lung-protective ventilation, prone ventilation, and neuromuscular blockade as needed. Further, a trial of pulmonary vasodilators is suggested for those who develop refractory hypoxemia. A review of the prior literature on inhaled pulmonary vasodilators in ARDS suggests only a transient improvement in oxygenation, with no mortality benefit. This narrative review aims to highlight the fundamental principles in ARDS management, delineate the fundamental differences between CARDS and ARDS, and describe the comprehensive use of inhaled pulmonary vasodilators. In addition, with the differing pathophysiology of CARDS from the typical ARDS, we sought to evaluate the current evidence regarding the use of inhaled pulmonary vasodilators in CARDS.Keywords
This publication has 95 references indexed in Scilit:
- Prostacyclin in the intensive care settingPediatric Critical Care Medicine, 2010
- Inhaled Prostanoids in the Therapy of Pulmonary HypertensionJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- Comparison of Two Fluid-Management Strategies in Acute Lung InjuryNew England Journal of Medicine, 2006
- Inhaled Nitric OxideCirculation, 2004
- Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2004
- The Toxicology of Inhaled Nitric OxideToxicological Sciences, 2001
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993
- Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin.Journal of Clinical Investigation, 1991
- Hypoxic pulmonary vasoconstriction in the adult respiratory distress syndromeActa Anaesthesiologica Scandinavica, 1991